Thermo Fisher Scientific Inc ($TMO) Stock Forecast: Down 7.2% Today

What is Thermo Fisher Scientific Inc?

Thermo Fisher Scientific (NYSE: TMO) is a prominent company in the scientific research and healthcare sector, recognized for its innovation and strong market position.

Why is Thermo Fisher Scientific Inc going down?

TMO stock is down 7.2% on Apr 24, 2025 13:38

• Surpassing Q1 expectations, Thermo Fisher adjusted its full-year forecast downward due to tariffs and rising expenses, leading to a decline in stock value.
• Despite a strong Q1, concerns from investors emerged regarding the impact of U.S.-China tariffs on revenue and operating income, resulting in a stock decline.
• Over the last 15 years, Thermo Fisher Scientific has consistently outperformed in the market, demonstrating resilience, but current challenges like tariffs and cost pressures are affecting short-term performance.

TMO Price Chart

TMO Technical Analysis

TMO News

Thermo Fisher Beats Q1 Estimates, Lowers Full-Year Forecast As Tariffs And Costs Take A Toll - Thermo Fisher Scientific ( NYSE:TMO )

Thermo Fisher slashed 2025 EPS guidance to $21.76-$22.84 vs. $23.25 consensus. U.S.-China tariffs expected to cut 2025 revenue by $400 million and operating income by $375 million. Markets are messy-but the right setups can still deliver triple-digit gains.

https://www.benzinga.com/general/health-care/25/04/44966173/thermo-fisher-beats-q1-estimates-lowers-full-year-forecast-as-tariffs-and-costs-take-a-toll

Why Is Thermo Fisher Scientific Stock Trading Higher On Wednesday? - Thermo Fisher Scientific ( NYSE:TMO )

Q1 adjusted EPS: $5.15 vs. $5.10 estimate; revenue: $10.36 billion vs. $10.23 billion expected. Life Sciences revenue rose 2.5%, Specialty Diagnostics up 3.5%, Biopharma fell 1.5%. Feel unsure about the market's next move?

https://www.benzinga.com/general/health-care/25/04/44956678/thermo-fisher-scientific-q1-earnings-surpass-estimates-ceo-touts-strong-performance-despite-e

$1000 Invested In Thermo Fisher Scientific 15 Years Ago Would Be Worth This Much Today - Thermo Fisher Scientific ( NYSE:TMO )

Thermo Fisher Scientific TMO has outperformed the market over the past 15 years by 4.46% on an annualized basis producing an average annual return of 14.73%. Currently, Thermo Fisher Scientific has a market capitalization of $159.15 billion.

https://www.benzinga.com/insights/news/25/04/44910802/1000-invested-in-thermo-fisher-scientific-15-years-ago-would-be-worth-this-much-today

Trending Today

Avalanche ($AVAX) Crypto Forecast: Up 5.4% Today

Cardano ($ADA) Crypto Forecast: Up 5.0% Today

Dogecoin ($DOGE) Crypto Forecast: Up 5.2% Today

Bonk ($BONK) Crypto Forecast: Down 5.4% Today

Litecoin ($LTC) Crypto Forecast: Up 6.5% Today

Monero ($XMR) Crypto Forecast: Down 5.4% Today

Wormhole ($W) Crypto Forecast: Up 5.2% Today

Sei ($SEI) Crypto Forecast: Up 6.7% Today

Worldcoin ($WLD) Crypto Forecast: Down 7.9% Today

Movement ($MOVE) Crypto Forecast: Down 17.7% Today

Thermo Fisher Scientific Inc Price History

06.00.2025 - TMO Stock was up 2.1%

• Strong bullish movement today can be attributed to TMO's impressive track record of outperforming the market over the last 20 years, with an annualized basis return of 15.55%.
• Investors are likely showing increased confidence in TMO's continued success and growth prospects, leading to a surge in buying activity.
• The positive sentiment surrounding TMO may have been further fueled by favorable market conditions and overall optimism in the scientific research sector.
• This bullish momentum is a testament to TMO's strong market position and investor appeal, reflecting a promising outlook for the company's future performance.

30.00.2025 - TMO Stock was up 5.4%

• Strong Q4 earnings were reported by Thermo Fisher Scientific, surpassing estimates with a 5% YoY sales growth, likely enhancing investor confidence in the company's performance.
• Margin expansion and a positive outlook from significant TMO options investors suggest optimism regarding the company's future prospects.
• The bullish market movement of TMO today may be linked to the favorable earnings report and the growing interest from informed investors, indicating trust in Thermo Fisher Scientific's growth path.

25.09.2023 - TMO Stock was down 6.0%

• Thermo Fisher Scientific Inc. (TMO) experienced a strong bearish movement today.
• The company reported lower revenues in its third quarter, with a 1% decrease compared to the previous year.
• Thermo Fisher also lowered its full-year financial outlook, citing weak biotech demand and a challenging macro environment.
• This news of lower revenues and a lowered outlook likely contributed to the bearish movement in TMO's stock price.

24.03.2025 - TMO Stock was down 7.2%

• Surpassing Q1 expectations, Thermo Fisher adjusted its full-year forecast downward due to tariffs and rising expenses, leading to a decline in stock value.
• Despite a strong Q1, concerns from investors emerged regarding the impact of U.S.-China tariffs on revenue and operating income, resulting in a stock decline.
• Over the last 15 years, Thermo Fisher Scientific has consistently outperformed in the market, demonstrating resilience, but current challenges like tariffs and cost pressures are affecting short-term performance.

10.03.2025 - TMO Stock was down 6.2%

• There was an 8.2% increase in Thermo Fisher's stock, which could potentially be an exaggerated response to past positive developments or market sentiment.
• Recent adjustments in earnings estimates not supporting further growth may have prompted investors to take profits, influencing the stock's bearish performance.
• Investor apprehension regarding the sustainability of Thermo Fisher's growth momentum could have resulted in a sell-off following the recent uptick.
• The downward movement might be a transient correction following the stock's rapid rise, rather than an indicator of prolonged weakness in the company's underlying fundamentals.

02.09.2023 - TMO Stock was down 1.7%

• Thermo Fisher Scientific (TMO) experienced a strong bearish movement today.
• The stock rating for TMO was lowered by StockNews.com.
• Despite the overall market dip, TMO managed to gain slightly.
• The bearish movement could be attributed to Bernstein's bearish outlook on Illumina, a competitor in the medtech industry.

31.09.2023 - TMO Stock was up 5.4%

• Unusual options activity suggests a bullish stance on TMO, indicating positive sentiment among investors.
• The acquisition of new positions by Peterson Financial Group Inc. and Apollon Wealth Management LLC also indicates confidence in TMO's growth potential.
• The reduction in stock holdings by Cognios Beta Neutral Large Cap Fund LP may be a minor factor, but overall sentiment remains bullish.
• The upgrade in rating to "Buy" by StockNews.com further supports the positive outlook for TMO.
• Overall, the bullish movement in TMO's stock today can be attributed to the positive sentiment among investors, as indicated by unusual options activity and the acquisition of new positions by prominent financial firms.

01.01.2024 - TMO Stock was down 5.1%

• The bearish movement in TMO's stock today could be attributed to the warning about lower-than-expected demand for 2024. This news may have raised concerns among investors about the company's future growth prospects. Additionally, the overall market sentiment towards biotech companies and their product spending could have contributed to the downward movement.

23.03.2024 - TMO Stock was up 5.0%

• Thermo Fisher Scientific is experiencing a surge in options activity, with deep-pocketed investors adopting a bullish approach towards the company, indicating confidence in its future prospects.
• The positive outlook for the Cell Cryopreservation Market, in which Thermo Fisher Scientific is a key player, could be contributing to the bullish movement as investors anticipate increased demand for the company's products and services.
• The overall market is eagerly awaiting key events such as the US core PCE print and corporate earnings reports, with Thermo Fisher Scientific standing out as a potential attractive valuation option, further attracting investors to the stock.
• The combination of favorable market conditions, positive industry trends, and investor sentiment towards Thermo Fisher Scientific could be driving the stock's strong bullish movement today.

01.06.2024 - TMO Stock was down 1.4%

• The bearish movement in TMO's stock today may be due to changes in investor focus within the biotech sector.
• The decline in vaccine sales post-pandemic and the current emphasis on long-term health solutions could be prompting investors to adjust their portfolios away from companies like TMO.
• Significant fund investors taking a bullish stance on TMO, as evidenced by options market data, could imply a short-term market correction rather than a sustained trend, which may be influencing today's bearish movement.
• It is crucial for traders to monitor evolving market dynamics, changing trends, and investor sentiments to make informed decisions within the biotech sector.

25.06.2024 - TMO Stock was up 5.7%

• Thermo Fisher Scientific (TMO) had a strong bullish movement today due to several positive factors:
• The company showcased its latest diagnostics innovations at the Association for Diagnostics & Laboratory Medicine Conference, highlighting industry developments and potential growth opportunities.
• Thermo Fisher's CEO, Marc Casper, had a positive discussion with Jim Cramer on "Mad Money," which likely boosted investor confidence.
• The company's Q2 earnings beat estimates and raised its full-year guidance, indicating strong financial performance and future prospects.
• Overall, these factors contributed to investor optimism and drove the bullish movement in TMO's stock price.

25.06.2024 - TMO Stock was up 5.3%

• Thermo Fisher Scientific presented its latest innovations at a conference, showcasing a dedication to advancements in diagnostics that probably bolstered investor confidence.
• A recent interview with the CEO on a finance show could have offered insights into the company's strong quarterly performance, potentially attracting more investor attention.
• TMO exceeded earnings expectations in Q2 and raised its fiscal year guidance, indicating strong financial performance and growth prospects, likely contributing to the stock's upward movement.
• Despite a slight revenue decline in Q2, the completion of the Olink acquisition and the improved profit forecast highlighted TMO's strategic efforts to strengthen its market position and profitability, reinforcing positive market sentiment towards the stock.